Last update 05 Mar 2025

LP-003 (Longbio Pharma)

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
LP 003, LP-003, LP003
Target
Mechanism
IgE inhibitors(Immunoglobulin E inhibitors)
Inactive Indication-
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Rhinitis, Allergic, SeasonalPhase 3
CN
30 Jul 2024
Allergic asthmaPhase 2
CN
07 Jan 2025
Chronic UrticariaPhase 2
CN
05 Jan 2024
AsthmaPhase 2-19 Jun 2023
Dermatitis, AtopicIND Approval
CN
03 Mar 2025
Food HypersensitivityIND Approval
CN
21 Nov 2024
Chronic rhinosinusitis with nasal polypsIND Approval
CN
18 Mar 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
-
opzaxuyaqb(cygjvkjtvj) = LP-003组患者瘙痒与风团症状评分(荨麻疹活动性评分UAS7)较基线降幅和实现症状完全消除(UAS7=0)的患者比例已超越奥马珠单抗组。 bcftcayrip (jxsjndxweo )
Positive
03 Mar 2025
Phase 2
180
LP-003 100mg
urjntayliw(bstgnbtynf) = iqlmygsgqd viwbjrlfid (nkynzydigr, 2.17)
Positive
25 Feb 2024
LP-003 200mg
-
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free